Stock & Company Details
Liquidia Corp $LQDA
Price:
N/A
N/A
90M
$5.2B
52 Week High:
N/A
10 Day Average Volume:
N/A
41.94
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
LQDA technical indicators
Latest Liquidia Corp (LQDA) indicator readings as of 2026-11-12.
LQDA's 14-day RSI is 68.7, in neutral territory. ADX reads 26.8, indicating a trending market. MACD (12, 26, 9) is 2.09, above the zero line.
Overview
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH). It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension.
Finance Bot
Ask your questions
Start by typing a question below.
